Use of siRNA targetting Sipa1l1 for the reduction of adipogenesis

Details for Australian Patent Application No. 2010302255 (hide)

Owner Sanofi

Inventors Hall, Diana; Jimenez, Maria; Poussin, Carine; Thorens, Bernard

Agent A J Park

Pub. Number AU-A-2010302255

PCT Pub. Number WO2011/039729

Priority 09305929.3 01.10.09 EP

Filing date 1 October 2010

Wipo publication date 7 April 2011

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

19 April 2012 PCT application entered the National Phase

  PCT publication WO2011/039729 Priority application(s): WO2011/039729

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010302266-Monitoring device for mangement of insulin delivery

2010302250-Antibodies that specifically bind to the EphA2 receptor